NOSHEEN HASAN: Open Payments
NPI 1003800285 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 63 payments from 14 companies in 2025. Trend: 2023 $1,124 · 2024 $1,382 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $555 |
| PFIZER INC. | 14 | $259 |
| Axsome Therapeutics, Inc. | 4 | $202 |
| Collegium Pharmaceutical, Inc. | 10 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $97 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $81 |
| Valinor Pharma, LLC | 2 | $38 |
| Orexo US, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $29 |
| Braeburn Inc. | 1 | $23 |
Products named: QULIPTA, NURTEC ODT, Symbravo, LINZESS, RELISTOR, XTAMPZA, JOURNAVX, Belbuca.
Industry payments across WI — which companies pay providers there.
